2022-07-01 2023-06-30 false Capium Accounts Production 1.1 06284161 bus:AbridgedAccounts 2022-07-01 2023-06-30 06284161 bus:FRS102 2022-07-01 2023-06-30 06284161 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 06284161 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 06284161 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 06284161 2022-07-01 2023-06-30 06284161 2023-06-30 06284161 bus:RegisteredOffice 2022-07-01 2023-06-30 06284161 core:WithinOneYear 2023-06-30 06284161 core:AfterOneYear 2023-06-30 06284161 bus:Director1 2022-07-01 2023-06-30 06284161 bus:Director1 2023-06-30 06284161 bus:Director1 2021-07-01 2022-06-30 06284161 2021-07-01 06284161 bus:CompanySecretary1 2022-07-01 2023-06-30 06284161 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 06284161 2021-07-01 2022-06-30 06284161 2022-06-30 06284161 core:WithinOneYear 2022-06-30 06284161 core:AfterOneYear 2022-06-30 06284161 bus:EntityAccountantsOrAuditors 2021-07-01 2022-06-30 06284161 bus:OrdinaryShareClass1 2022-07-01 2023-06-30 06284161 bus:OrdinaryShareClass1 2023-06-30 06284161 bus:OrdinaryShareClass1 2021-07-01 2022-06-30 06284161 bus:OrdinaryShareClass1 2022-06-30 06284161 core:ComputerEquipment 2022-07-01 2023-06-30 06284161 core:ComputerEquipment 2023-06-30 06284161 core:ComputerEquipment 2022-06-30 06284161 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-06-30 06284161 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-06-30 06284161 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 06284161 core:CostValuation core:Non-currentFinancialInstruments 2022-06-30 06284161 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-06-30 06284161 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 06284161 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 06284161 core:Non-currentFinancialInstruments 2023-06-30 06284161 core:Non-currentFinancialInstruments 2022-06-30 06284161 core:ShareCapital 2023-06-30 06284161 core:ShareCapital 2022-06-30 06284161 core:RetainedEarningsAccumulatedLosses 2023-06-30 06284161 core:RetainedEarningsAccumulatedLosses 2022-06-30 06284161 dpl:Item1 2022-07-01 06284161 dpl:Item1 2023-06-30 06284161 dpl:Item1 2021-07-01 06284161 dpl:Item1 2022-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 06284161
England and Wales

 

 

 

BASIT-MEDICAL LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 July 2022

End date: 30 June 2023
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 2,003    359 
2,003    359 
Current assets      
Cash at bank and in hand 19,256    28,468 
Creditors: amount falling due within one year (28,856)   (24,502)
Net current liabilities (9,600)   3,966 
 
Total assets less current liabilities (7,597)   4,325 
Net liabilities (7,597)   4,325 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account (7,697)   4,225 
Shareholder's funds (7,597)   4,325 
 


For the year ended 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 March 2024 and were signed by:


-------------------------------
Behzad BOROUMAND BASIT
Director
1
General Information
Basit-Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 06284161, registration address 61 Bridge Street, Kington, England, HR5 3DJ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 20% Reducing Balance
Assets on finance lease and hire purchase
Assets held under finance lease or hire purchase contracts i.e. those contracts where substantially all the risks and rewards of ownership have passed to the company, are included in the appropriate category of tangible fixed assets and depreciated over the shorter of the lease term and their estimated expected useful lives.
Future obligations under such contracts are included in creditors net of the finance charge allocated to future periods.
2.

Average number of employees

Average number of employees during the year was 0 (2022 : 0).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 July 2022 3,238    3,238 
Additions 2,145    2,145 
Disposals  
At 30 June 2023 5,383    5,383 
Depreciation
At 01 July 2022 2,879    2,879 
Charge for year 501    501 
On disposals  
At 30 June 2023 3,380    3,380 
Net book values
Closing balance as at 30 June 2023 2,003    2,003 
Opening balance as at 01 July 2022 359    359 


4.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
100 Class A shares of £1.00 each 100    100 
100    100 

2